Sean Dodge
Stock Analyst at RBC Capital
(2.06)
# 3,008
Out of 5,012 analysts
131
Total ratings
32.99%
Success rate
-1.78%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Sector Perform | $7 → $6 | $2.85 | +110.53% | 10 | Feb 27, 2025 | |
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $1.06 | +230.19% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $200.86 | +34.42% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $8.37 | +43.37% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $186.65 | +40.91% | 2 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $8.12 | +109.36% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $23.41 | +36.69% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $17.95 | -66.57% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $88.50 | +18.64% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $16.08 | +5.72% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $37.91 | -10.31% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $20.06 | -30.21% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $4.39 | +127.79% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $24.02 | +16.57% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $15.92 | -12.06% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $194.39 | -83.02% | 1 | Sep 14, 2022 |
Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $2.85
Upside: +110.53%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $1.06
Upside: +230.19%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $200.86
Upside: +34.42%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $8.37
Upside: +43.37%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $186.65
Upside: +40.91%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $8.12
Upside: +109.36%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $23.41
Upside: +36.69%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $17.95
Upside: -66.57%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $88.50
Upside: +18.64%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $16.08
Upside: +5.72%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $37.91
Upside: -10.31%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $20.06
Upside: -30.21%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $4.39
Upside: +127.79%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $24.02
Upside: +16.57%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $15.92
Upside: -12.06%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $194.39
Upside: -83.02%